Skip to main content
Clinical Trials/IRCT20220219054066N1
IRCT20220219054066N1
Completed
Phase 2

Safety and efficacy of Radiofrequency ablation of abdominal wall endometriosis

Iranian academic center for education culture and research0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Iranian academic center for education culture and research
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Iranian academic center for education culture and research

Eligibility Criteria

Inclusion Criteria

  • Abdominal Wall Endometriosis diagnosis
  • no history of abdominal wall surgery over the past three months
  • patients without severe comorbidities, such as hypertension or diabetes
  • patients could tolerate 1\-2 hours under general anesthesia

Exclusion Criteria

  • Patients with more than 1 abdominal wall endometriosis lesion
  • Abdominal wall endometriosis lesion volume of over 50 cc
  • Past surgical history of resection of abdominal wall endometriosis
  • Past medical history of heart failure
  • Allergy to cephalexin and lidocain

Outcomes

Primary Outcomes

Not specified

Similar Trials